# Relmada Therapeutics, Inc.: Form DEF 14A, filed Dec 30, 2016

- Company: [Relmada Therapeutics, Inc.](/companies/rlmd.md) (CIK 1553643)
- Form: DEF 14A
- Filed: 2016-12-30
- Accepted by EDGAR: Dec 30, 2016, 16:17 ET
- Period: 2016-01-27
- Accession: 0001213900-16-019804
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1553643/000121390016019804/def14a1116_relmada.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1553643/000121390016019804/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1553643/000121390016019804/def14a1116_relmada.htm

Filed Dec 30, 2016.
Source: SEC EDGAR, the filing index for accession 0001213900-16-019804. Last ingested by Listed: Nov 13, 2026, 15:42 ET. No prices; not investment advice.
